CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 156 filers reported holding CLOVIS ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $3,471,000 | -6.0% | 65,739 | +21.0% | 0.03% | +7.7% |
Q4 2017 | $3,693,000 | +108.8% | 54,314 | +10.7% | 0.03% | +85.7% |
Q3 2016 | $1,769,000 | +139.1% | 49,083 | -9.0% | 0.01% | +100.0% |
Q2 2016 | $740,000 | -10.5% | 53,924 | +25.1% | 0.01% | -22.2% |
Q1 2016 | $827,000 | -53.2% | 43,096 | -14.6% | 0.01% | -47.1% |
Q4 2015 | $1,767,000 | -96.7% | 50,481 | -14.2% | 0.02% | -70.2% |
Q3 2015 | $54,105,000 | +1724.2% | 58,835 | +74.3% | 0.06% | +128.0% |
Q2 2015 | $2,966,000 | +135.8% | 33,756 | +99.2% | 0.02% | +150.0% |
Q1 2015 | $1,258,000 | – | 16,946 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |